Dmceng-Tony Frudakis said at the meeting, "I'm tired of people flipping the stock..."
They are not going to tell us at all when DNAG/M2Gen news will be out...
M2Gen is getting started, so is suspect this news will be soon.
Merck seems to be slow in moving.. I suspect Tony is a little aggressive to make all drugs DNA based, so Merck is concerned. Tony wants to jump out of just cancer drugs, though at least, Merck will eventually fund the Cancer drugs..
Tony Frudakis is a bit gong ho on personalized medicine...
GOOD for us, but if Merck wants him to concentrate on cancer first, so be it..
We need to get this going!